Morgan Stanley’s Cantel Medical Corporation CMD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-33,970
Closed -$2.71M 7946
2021
Q1
$2.71M Sell
33,970
-47,824
-58% -$3.82M ﹤0.01% 4018
2020
Q4
$6.45M Buy
81,794
+35,689
+77% +$2.81M ﹤0.01% 2987
2020
Q3
$2.03M Sell
46,105
-79,608
-63% -$3.5M ﹤0.01% 3646
2020
Q2
$5.56M Buy
125,713
+66,285
+112% +$2.93M ﹤0.01% 2555
2020
Q1
$2.13M Buy
59,428
+10,991
+23% +$394K ﹤0.01% 3311
2019
Q4
$3.43M Buy
48,437
+19,971
+70% +$1.42M ﹤0.01% 3593
2019
Q3
$2.13M Sell
28,466
-2,862
-9% -$214K ﹤0.01% 3730
2019
Q2
$2.53M Sell
31,328
-4,614
-13% -$372K ﹤0.01% 3591
2019
Q1
$2.4M Buy
35,942
+11,249
+46% +$752K ﹤0.01% 3429
2018
Q4
$1.84M Sell
24,693
-128,301
-84% -$9.55M ﹤0.01% 3840
2018
Q3
$14.1M Sell
152,994
-77,381
-34% -$7.12M ﹤0.01% 2043
2018
Q2
$22.7M Buy
230,375
+42,643
+23% +$4.19M 0.01% 1517
2018
Q1
$20.9M Buy
187,732
+32,258
+21% +$3.59M 0.01% 1621
2017
Q4
$16M Buy
155,474
+85,247
+121% +$8.77M ﹤0.01% 1907
2017
Q3
$6.61M Buy
70,227
+11,457
+19% +$1.08M ﹤0.01% 2673
2017
Q2
$4.58M Sell
58,770
-6,350
-10% -$495K ﹤0.01% 2935
2017
Q1
$5.22M Sell
65,120
-128,030
-66% -$10.3M ﹤0.01% 2824
2016
Q4
$15.2M Buy
193,150
+149,818
+346% +$11.8M 0.01% 1803
2016
Q3
$3.38M Sell
43,332
-148,950
-77% -$11.6M ﹤0.01% 3050
2016
Q2
$13.2M Buy
192,282
+174,401
+975% +$12M ﹤0.01% 1754
2016
Q1
$1.28M Sell
17,881
-30,501
-63% -$2.17M ﹤0.01% 3723
2015
Q4
$3.01M Buy
48,382
+31,633
+189% +$1.97M ﹤0.01% 3141
2015
Q3
$949K Sell
16,749
-27,404
-62% -$1.55M ﹤0.01% 4150
2015
Q2
$2.37M Buy
44,153
+22,042
+100% +$1.18M ﹤0.01% 3466
2015
Q1
$1.05M Buy
22,111
+203
+0.9% +$9.65K ﹤0.01% 4095
2014
Q4
$948K Sell
21,908
-33,580
-61% -$1.45M ﹤0.01% 4196
2014
Q3
$1.91M Buy
55,488
+1,774
+3% +$61K ﹤0.01% 3478
2014
Q2
$1.97M Sell
53,714
-33,598
-38% -$1.23M ﹤0.01% 3497
2014
Q1
$2.94M Sell
87,312
-175,034
-67% -$5.9M ﹤0.01% 3091
2013
Q4
$8.9M Buy
262,346
+211,825
+419% +$7.18M ﹤0.01% 2051
2013
Q3
$1.61M Buy
50,521
+38,107
+307% +$1.21M ﹤0.01% 3407
2013
Q2
$281K Buy
+12,414
New +$281K ﹤0.01% 4640